Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma
- Resource Type
- Article
- Source
- In
ESMO Open August 2023 8(4) - Subject
Gastrointestinal Cancers - Language
- ISSN
- 2059-7029